Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study
作者
Martin H. Kropff,Martin Vogel,Guido Bisping,Rudolf Schlag,Rudolf Weide,Wolfgang Ulrich Knauf,Heinrich Fiechtner,Georgi Kojouharoff,Stephan Kremers,Wolfgang E. Berdel
出处
期刊:Annals of Hematology [Springer Science+Business Media] 日期:2017-09-13卷期号:96 (11): 1857-1866被引量:19